Literature DB >> 13805389

Pelvic exenteration operations: with summary of sixty-six cases surviving more than five years.

A BRUNSCHWIG, W DANIEL.   

Abstract

Keywords:  CERVIX NEOPLASMS/surgery; PELVIS/surgery

Mesh：

Year:  1960        PMID： 13805389      PMCID： PMC1613585          DOI： 10.1097/00000658-196004000-00018

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  1 in total

1.  Evaluation of pelvic exenteration for advanced cancer of the cervix.

Authors:  A BRUNSCHWIG; W DANIEL
Journal:  Surg Gynecol Obstet       Date:  1956-09
  1 in total
  7 in total

Review 1.  Is total pelvic exenteration reasonable primary treatment for rectal carcinoma?

Authors:  L F Williams; C B Huddleston; J L Sawyers; J R Potts; K W Sharp; S W McDougal
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

2.  Extensive resections for cancer of the large bowel.

Authors: 
Journal:  Br Med J       Date:  1973-03-24

3.  Total pelvic exenteration in colorectal disease: A 20-year experience.

Authors:  E J Ledesma; S Bruno; A Mittelman
Journal:  Ann Surg       Date:  1981-12       Impact factor: 12.969

4.  Revisiting the double-barreled wet colostomy for simultaneous urinary and fecal diversion--an Indian experience.

Authors:  Sudhir Sukumar; E Sivanandam; H Sanjay Bhat; Georgie Mathew; O V Sudheer; Puneet Dhar
Journal:  Indian J Gastroenterol       Date:  2011-01-11

5.  Radical bladder surgery.

Authors: 
Journal:  Br Med J       Date:  1967-01-28

6.  Pelvic exenteration for locally advanced colorectal carcinoma.

Authors:  J Boey; J Wong; G B Ong
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

7.  Predictors of overall survival following extended radical resections for locally advanced and recurrent pelvic malignancies.

Authors:  Joseph C Kong; Oliver Peacock; Peadar S Waters; Tim Eglinton; Satish K Warrier; Christopher Wakeman; Frank A Frizelle; Alexander G Heriot; Jacob J McCormick
Journal:  Langenbecks Arch Surg       Date:  2020-06-12       Impact factor: 3.445
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.